Markets:

Overview

News

Currencies

International

Treasuries

ARK Genomic Revolution ETF (NY:ARKG)

29.55 -0.11 (-0.37%)

Streaming Delayed Price Updated: 11:17 AM EST, Feb 19, 2026 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

All News News Headlines Press Releases

Research

Quarterly Reports Insider Filings Other Filings

All News about ARK Genomic Revolution ETF

< Previous 1 2

...

4 5 6 7 8 9 10 11 Next >

Cathie Wood Continues Investing In Psychedelics, She Bought Over 3M Atai Shares In July Alone ↗

August 03, 2022

Several weeks ago, Cathie Wood's ARK Fund (BATS: ARKG) invested in the biotech psychedelics sector, specifically in major player

Via Benzinga

'Teladoc Will Become A Premier Enterprise Partner': Why Cathie Wood Is Buying The Dip And Remains Bullish On Teladoc ↗

July 31, 2022

Virtual healthcare provider Teladoc Health (NYSE: TDOC) has been a favorite stock pick of Cathie Wood, CEO of Ark Invest. After shares dropped 18% on Thursday from second quarter financial results,...

Via Benzinga

Small Cap Biotech Stocks Are Trending Well ↗

July 18, 2022

Despite a little weakness last week, small cap biotechs are trending well for traders. For investors entering the trade on July 5 all of our. focus stocks are up except ChemoCentryx.

Via Talk Markets

Cathie Wood's Ark Invest Sheds $35M In 3D Printing Company Stratasys — What It Bought Instead ↗

July 06, 2022

As the market reopened following the long July 4 weekend, Cathie Wood-run Ark Invest made some portfolio moves, notable among which is the offloading of a huge chunk of Stratasys Ltd. (NASDAQ: SSYS)...

Via Benzinga

Filling Cathie’s Gap ↗

June 22, 2022

Keep an eye on these gaps closing as an exhaustion point for the brief recovery Ms. Wood is enjoying.

Via Talk Markets

A Leaky ARKK ↗

January 04, 2022

In a year when everything skyrocketed to nauseating highs, Cathie’s momentum-obsessed investing style was a dud.

Via Talk Markets

Neck Cream Reversal ↗

November 18, 2021

Cathie Wood's ARKG is down about 50% over the past 9 months.

Via Talk Markets

5 Cathie Wood Stocks to Buy in June ↗

June 09, 2022

These are the five best Cathie Wood stocks to buy in June. EXAS, IONS, KTOS, TRMB, and PATH can make excellent investments.

Via InvestorPlace

Cathie Wood Trims Pfizer Stake And Loads Up $25M In Rival COVID-19 Vaccine Maker ↗

June 09, 2022

Cathie Wood led Ark Invest on Wednesday initiated a position in Moderna Inc (NASDAQ: MRNA) after the biotech company said an updated version of its COVID-19 booster vaccine appeared to provide strong

Via Benzinga

Cathie Wood Is Selling Gene Editing Stocks. Here’s Why. ↗

June 02, 2022

Cathie Wood has recently sold off large positions in several gene-editing stocks from her ARKG ETF. What's behind Wood's latest moves?

Via InvestorPlace

Know The 2 Healthcare Companies Cathie Wood's Ark Invest Bought On Friday ↗

April 02, 2022

Cathie Wood's Ark Invest may have had a disappointing 2021, but the fund's purchases/liquidations are always watched keenly by investors. On Friday, ETFs managed by...

Via Benzinga

Tesla Bull Cathie Wood Bought $1M Shares In This Biotech Stock Today ↗

March 24, 2022

Tesla Inc (NASDAQ: TSLA) bull Cathie Wood led Ark Investment Management on Thursday further raised its exposure in China-based biotech company Burning Rock Biotech Ltd (NASDAQ: BNR).

Via Benzinga

4 Big Ark Innovation Components Report Earnings This Week: Could It Spell More Danger For Cathie Wood? ↗

February 23, 2022

The Ark Funds ETFs have been hit hard in 2022 with growth stocks among the laggards as investors turned to value stocks. Many stockholders have begun to question ...

Via Benzinga

Psyched: Cathie Wood Invests In Psychedelics Co ATAI, Bill Approved in Utah, AI Startup To 'Design States Of Mind' ↗

February 14, 2022

The psychedelics sector received its latest sign of acceptance from Wall Street with famed investor Cathie Wood taking a position ...

Via Benzinga

Cathie Wood Is Buying this Peter Thiel-Backed Psychedelics Stock For Ark Funds ↗

February 09, 2022

There’s a new psychedelics company being added to an ETF from Cathie Wood. What Happened: The Ark Genomic Revolution ETF (BATS: ARKG) took an initial position in shares of...

Via Benzinga

Cathie Wood's Ark Invest Sheds Stake In This Large-Cap Pharma Ahead Of Earnings ↗

February 05, 2022

Big pharma reporting season was muted, with the quarterly results and guidance coming in mixed.

Via Benzinga

Ark Funds Launching New Fund That Could Invest In Private Companies ↗

February 04, 2022

One of the biggest and most well-known ETF companies is launching a new closed-end fund that provides major differences from its existing ETFs.

Via Talk Markets

Ark Funds Launching New Fund That Could Invest In Private Companies ↗

February 04, 2022

One of the biggest and most well-known ETF companies is launching a new closed-end fund that provides major differences from its existing ETFs....

Via Benzinga

Small Cap Biotech Stocks: Is it time to start trading? ↗

January 31, 2022

It’s time to trade beaten-up small cap biotech stocks.

Via Talk Markets

Benzinga Asks: Which ARK Fund Would You Rather Buy And Hold For 5 Years? ↗

January 14, 2022

One of the best-known and well-covered ETF companies over the past five years has been ARK Invest, led by Cathie Wood. With t...

Via Benzinga

UiPath Stock Is Worth Believing in Here as Wood Holds Fast ↗

December 30, 2021

Cathie Woods ARK Investment ETFs have loaded up on shares of UiPath despite the decline. PATH stock has plenty of upside from here.

Via InvestorPlace

Biotech Playbook 2021 Part 2: Rotation Rally Brings Relief after FED Pivot ↗

December 22, 2021

The new aggressive Fed taper combined with a rise in interest rates for 2022 adds a new element of risk to portfolio management. Monetary policy is a headwind for 2022.

Via Talk Markets

Cathie Wood Added To Stake In This Medical Technology Company As Its Shares Surged 6% On Friday ↗

December 20, 2021

Cathie Wood’s Ark Investment Management on Friday bought 26,126 shares — estimated to be worth $163,026 — in Quantum-Si Inc (NASDAQ: QSI). Shares of the medical...

Via Benzinga

Biotech Playbook 2021: No Help From Small Caps In Q4 ↗

December 14, 2021

Mid-cap stock picks have done better today but are way off their 2021 highs. Cryoport and Veracyte are still up and look better technically. Quidel was up 5.48% today on Omicron concerns globally but...

Via Talk Markets

Bionano Genomics Proves Not Everything Genetic is Gold ↗

December 01, 2021

Bionano sells a $150,000 machine called Saphyr that does genetic mapping. It's a solid device, but its future remains in the future, as do BNGO stock fortunes.

Via InvestorPlace

Cathie Wood Testing 'ARK On Steroids' As ARK Funds Struggle ↗

November 24, 2021

Wood said ARK is testing a strategy to short stocks in the big benchmark indexes,

Via Investor's Business Daily

Topics Electric Vehicles

Don't Look Now, But Cathie Wood's Ark Is Taking On Water ↗

November 24, 2021

Among the biggest losers over the last 48 hour tech stock volatility has been...well, everything in Cathie Wood's

Via Talk Markets

Biotech Stocks are Due for a Rally ↗

November 22, 2021

There are many rebalancing trades left in your stock portfolio but biotech is in the doldrums.

Via Talk Markets

Yes, Cathie Wood's $700,000 Bitcoin Price Prediction Is Legit ↗

November 21, 2021

A Bitcoin price prediction of $700,000 - more than 10 times the recent price - would strike most people as delusional. But this eye-popping target doesn't come from a Bitcoin fan. It comes from Wall...

Via Talk Markets

Tesla (TSLA) Not Enough To Lift ARK Innovation (ARKK) ↗

October 27, 2021

An updated look at Cathie Wood’s ARK ETFs relative strength versus the S&P 500 SPY ETF.

Via Talk Markets

Topics Stocks

< Previous 1 2

...

4 5 6 7 8 9 10 11 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.